Su-Kyeong Eo

ORCID: 0000-0003-1716-1567
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • SARS-CoV-2 and COVID-19 Research
  • Viral Infections and Outbreaks Research
  • Animal Virus Infections Studies
  • Vector-Borne Animal Diseases
  • SARS-CoV-2 detection and testing
  • Virology and Viral Diseases
  • Viral Infections and Immunology Research
  • Viral Infections and Vectors
  • Viral gastroenteritis research and epidemiology
  • Cancer Immunotherapy and Biomarkers
  • interferon and immune responses
  • Immune Cell Function and Interaction
  • Respiratory viral infections research
  • CAR-T cell therapy research
  • Influenza Virus Research Studies

International Vaccine Institute
2021

Korea Research Institute of Bioscience and Biotechnology
2021

Korea Advanced Institute of Science and Technology
2018-2019

Although the incidence of severe fever with thrombocytopenia syndrome virus (SFTSV) infection has increased from its discovery a mortality rate 10-20%, no effective vaccines are currently available. Here we describe development SFTSV DNA vaccine, immunogenicity, and protective efficacy. Vaccine candidates induce both neutralizing antibody response multifunctional SFTSV-specific T cell in mice ferrets. When vaccine efficacy is investigated aged-ferrets that recapitulate fatal clinical...

10.1038/s41467-019-11815-4 article EN cc-by Nature Communications 2019-08-23

The development of safe and effective vaccines to prevent SARS-CoV-2 infections remains an urgent priority worldwide. We have used a recombinant vesicular stomatitis virus (rVSV)-based prime-boost immunization strategy develop COVID-19 vaccine candidate. constructed VSV genomes carrying exogenous genes resulting in the production avirulent rVSV full-length spike protein (SF), S1 subunit, or receptor-binding domain (RBD) plus envelope (E) SARS-CoV-2. Adding honeybee melittin signal peptide...

10.1371/journal.ppat.1010092 article EN cc-by PLoS Pathogens 2021-12-16

Abstract P.1. or gamma variant also known as the Brazil variant, is one of variants concern (VOC) which appears to have high transmissibility and mortality. To explore potency CT-P59 monoclonal antibody against P.1 we tried conduct binding affinity, in vitro neutralization, vivo animal tests. In assays revealed that able neutralize spite reduction its affinity a RBD (receptor domain) mutant protein including K417T/E484K/N501Y neutralizing activity pseudoviruses live viruses. contrast, hACE2...

10.1101/2021.07.08.451696 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2021-07-09
Coming Soon ...